Join the 'Stye' group to help and get support from people like you.
Posted 12 Sep 2011 by Drugs.com
MONDAY, Sept. 12 – Repeated use of antibiotics among patients who receive eye injections for such ophthalmic conditions as age-related macular degeneration can lead to the emergence of drug-resistant germs, according to a new study. More than eight million people in the United States are affected by age-related macular degeneration, and its treatment involves monthly injections that are typically followed by antibiotics to prevent such complications as inflammation of the eye. Researchers from Vanderbilt University School of Medicine in Nashville found, however, that long-term use of antibiotics after eye injection therapy may promote the growth of hard-to-treat germs. "Repeated exposure of ocular flora [microbes living on or inside the body] ... may select for resistant bacterial strains and cultivate 'superbugs' with multiple-drug resistance ..." the study's authors wrote a news ... Read more
Related support groups: Macular Degeneration, Vigamox, Zymar, Sulfacetamide Sodium, Povidone Iodine, Lucentis, Stye, Boric Acid, Azasite, Polytrim, Polymyxin B/Trimethoprim, Tobrex, Silver Nitrate, Zymaxid, Zirgan, Besivance, Ciloxan, Ocuflox, Natacyn, Moxeza
Ask a Question
Related Condition Support Groups
Related Drug Support Groups
Polycin, Polycin-B, bacitracin / polymyxin b, Neo-Polycin, bacitracin / neomycin / polymyxin b, Ocutricin, Neocin, Ocu-Spore-B, AK-Poly-Bac, Polytracin Ophthalmic, Polysporin Ophthalmic, Neocidin, AK-Spore Ointment